EFFECTIVENESS OF THE NEUROADAPTATIVE FOR URGE INCONTINENCE

Inclusion Criteria: * Urge incontinence or mixed incontinence without urethral hypermobility * Over 3 months of disease evolves. Exclusion Criteria: * Severe physical limitations that might interfere with applying the treatment. * Severe mental disorders that need pharmacology treatments that may influence in neuronal activity * Oncological processes in the lower abdomen that had required radical surgery. * Neurogenic bladder. * Blockage of the bladder * Vaginal infection * Bladder infection or disorder of kidney function * Have received, in the last year, botulinum toxin in bladder or pelvic organs. * Have received pharmacological treatment for urge incontinence in the last month (before entry date in the trial) * Be receiving pharmacological treatment for urge incontinence. * Stress incontinence due to urethral hypermobility which was treatable with surgery. * Pregnant women * Patients with pacemarker